| Jessica Kreidler, AUD, CCC-A | |
|
8301 Arlington Blvd Ste 302, Fairfax, VA 22031-2902 | |
| (703) 204-1123 | |
| (703) 645-0793 |
| Full Name | Jessica Kreidler |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 4 Years |
| Location | 8301 Arlington Blvd Ste 302, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760096366 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2201001795 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Audiology Associates Inc. | 4981626389 | 14 |
News Archive
Stating that neglected tropical diseases (NTDs) not only promote poverty but also destabilize communities, former Health and Human Services Secretary Tommy Thompson and Sabin Vaccine Institute President Peter Hotez call upon the public-health and foreign-policy communities to embrace medical diplomacy and NTD control as a means to combat terrorism in an article published January 27 in the open-access journal PLoS Neglected Tropical Diseases.
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for lidocaine topical patch 5%, the generic equivalent to Endo's Lidoderm.
Study findings corroborate that patients with schizophrenia who receive outpatient care only during the early stages of their illness have better outcomes than those requiring inpatient hospitalization.
› Verified 9 days ago
| Provider Name | Audiology Associates Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942325527 PECOS PAC ID: 4981626389 Enrollment ID: O20200709001790 |
News Archive
Stating that neglected tropical diseases (NTDs) not only promote poverty but also destabilize communities, former Health and Human Services Secretary Tommy Thompson and Sabin Vaccine Institute President Peter Hotez call upon the public-health and foreign-policy communities to embrace medical diplomacy and NTD control as a means to combat terrorism in an article published January 27 in the open-access journal PLoS Neglected Tropical Diseases.
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for lidocaine topical patch 5%, the generic equivalent to Endo's Lidoderm.
Study findings corroborate that patients with schizophrenia who receive outpatient care only during the early stages of their illness have better outcomes than those requiring inpatient hospitalization.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Kreidler, AUD, CCC-A 8301 Arlington Blvd Ste 302, Fairfax, VA 22031-2902 Ph: (703) 204-1123 | Jessica Kreidler, AUD, CCC-A 8301 Arlington Blvd Ste 302, Fairfax, VA 22031-2902 Ph: (703) 204-1123 |
News Archive
Stating that neglected tropical diseases (NTDs) not only promote poverty but also destabilize communities, former Health and Human Services Secretary Tommy Thompson and Sabin Vaccine Institute President Peter Hotez call upon the public-health and foreign-policy communities to embrace medical diplomacy and NTD control as a means to combat terrorism in an article published January 27 in the open-access journal PLoS Neglected Tropical Diseases.
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for lidocaine topical patch 5%, the generic equivalent to Endo's Lidoderm.
Study findings corroborate that patients with schizophrenia who receive outpatient care only during the early stages of their illness have better outcomes than those requiring inpatient hospitalization.
› Verified 9 days ago
Dr. Olivia Marie Planas, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3801 University Dr Fl 3, Fairfax, VA 22030 Phone: 703-383-8130 | |
Andrea Rae Markway, AUD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3801 University Dr, 2nd Floor, Fairfax, VA 22030 Phone: 703-383-8130 | |
Caroline Elaine Miller, Audiologist Medicare: Medicare Enrolled Practice Location: 3801 University Dr Fl 3, Fairfax, VA 22030 Phone: 703-383-8130 | |
Mrs. Julie Ann Dubois, M.S. Audiologist Medicare: Medicare Enrolled Practice Location: 8316 Arlington Blvd, Suite 300, Fairfax, VA 22031 Phone: 703-573-7600 Fax: 703-560-3808 | |
Dr. Brooke Dillard, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3801 University Dr Fl 3, Fairfax, VA 22030 Phone: 703-383-8130 | |
Candace Ann Thorp-feather, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3801 University Dr, Suite 200, Fairfax, VA 22030 Phone: 703-383-8130 Fax: 703-383-7353 | |
Lori Hanline, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8316 Arlington Blvd, Suite 300, Fairfax, VA 22031 Phone: 703-573-7600 Fax: 703-573-2694 |